A detailed history of Tria Gen Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tria Gen Wealth Management LLC holds 3,119 shares of ABBV stock, worth $532,319. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,119
Previous 3,119 -0.0%
Holding current value
$532,319
Previous $615,000 9.92%
% of portfolio
0.2%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $138,563 - $157,880
-867 Reduced 21.75%
3,119 $567,000
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $3,740 - $4,330
-28 Reduced 0.7%
3,986 $594,000
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $3,842 - $4,782
-29 Reduced 0.72%
4,014 $540,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $11,134 - $12,823
77 Added 1.94%
4,043 $644,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $2,074 - $2,488
-15 Reduced 0.38%
3,966 $641,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $254,597 - $323,676
-1,850 Reduced 31.73%
3,981 $610,000
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $43,025 - $53,382
-326 Reduced 5.29%
5,831 $945,000
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $235,379 - $297,822
-2,191 Reduced 26.25%
6,157 $834,000
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $466,244 - $529,257
4,382 Added 110.49%
8,348 $900,000
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $11,257 - $12,541
-107 Reduced 2.63%
3,966 $461,000
Q1 2021

Apr 26, 2021

SELL
$102.3 - $112.62 $6,649 - $7,320
-65 Reduced 1.57%
4,073 $441,000
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $333,067 - $449,676
4,138 New
4,138 $443,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tria Gen Wealth Management LLC Portfolio

Follow Tria Gen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tria Gen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tria Gen Wealth Management LLC with notifications on news.